large doses of fl-adrenergic agonist bronchodilators should probably also be excluded. Before being given a canister for self-administration, suitable patients should be investigated routinely to discover the dose he or she needs to inhale to raise the pulse rate by twenty to thirty beats per minute. If this dose was inhaled immediately the patient began to develop angioedema, an amount sufficient to abort the attack might be absorbed. The number of inhalations required should preferably be determined in specialist centres in order to exclude from this treatment the occasional patient who develops a dysrhythmia after inhaling quite small doses of isoprenaline.
It is generally agreed that the most effective initial treatment for any patient with anaphylaxis is adrenaline by deep subcutaneous or, if the patient is severely shocked, by intramuscular injection (see, for instance, Lancet 1980 , British Medical Journal 1981 , Frankland & Lessof 1980 , 1981 , Lancaster 1980 . Patients who have just been stung and who have had a severe reaction in the past are usually frightened and may find themselves unable to open an ampoule and fill a syringe and then inject themselves during a time when their symptoms are increasing in severity. Syringes precharged with adrenaline have not recently been available in the UK (British Medical Journal 1979 , Brown 1980 , but now can be obtained easily (Ackroyd 1980) . It is strongly recommended that any patient who has had a severe reaction and who seems likely to be able to use such a syringe should be given one and taught how to use it. The dose of adrenaline with which the patient should inject himself should be determined in a manner similar to that suggested for determining the dose of inhaled isoprenaline. J F Ackroyd
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The infection-prone hospital patient
To those of us who remember pre-penicillin days, the achievements of antibiotics are nothing short of miraculous. We can now cure diseases like bacterial endocarditis and tuberculous meningitis which in those days were always lethal.
The impact of antibiotics in surgical practice, however, has been less dramatic and no amount of the newest and most expensive antibiotic can make up for bad surgery, or rescue the patient who is profoundly septic. The considerable new vocabulary embracing septic shock, shock lung and multiple organ failure is testimony to this.
Infections are caused by microorganisms whose number and virulence determine their aggres-siveness which, in turn, is limited by the defences of the host. Aspects of this relationship were debated at a meeting of the Section of Surgery held on 4 March 1981.
The defence starts with capillary dilatation, stasis and increased permeability. Protein-rich fluid containing. immunoglobulins escapes and surrounds the invaders. Neutrophils stick to the capillary walls, haul themselves through by diapedesis, and make straight for the bacteria, which they engulf. Intracellular killing is accomplished (provided sufficient oxygen is available) by lysozyme and by the superoxideperoxide reaction (Hunt et 01. 1975); finally, tissue and blood macrophages clean up the battlefield, remove all dead cells and retire in favour of the fibroblasts of the repair phase.
The control of this intricate process has attracted a lot of attention recently. Activated complement is of central importance, and it is here that T lymphocytes play their part. To many microorganisms these cells have built up a memory of immunity, on which the classical pathway of complement activation IgG and IgM depends. The alternative (properdin) pathway is, however, probably more important in resistance to infection (Fearon & Austen 1980) . In either event, activated complement assists the chemotaxis of neutrophils towards invading microbes, and opsonizes bacteria for phagocytosis. Splenectomy in infants results in increased susceptibility to infections for at least two years, probably due to deficient production of opsonizing antibodies. Intracellular killing of bacteria by neutrophils depends on oxygen availability more than anything else, but there are rare conditions like chronic granulomatous disease in which neutrophil enzymes are deficient.
Protein-calorie malnutrition (defined by measuring forearm circumference, triceps skinfold thickness, weight loss, and serum levels of albumin and total iron-binding capacity or transferrin) depresses cell-mediated immunity and the pathways of complement activation (Suskind et 01. 1978) . Repletion of iron stores, on the other hand, has a deleterious effect on host resistance to infection (Murray et 01. 1978), and steroids not only depress T lymphocyte production but also interfere with neutrophil killing. .
What is the application of all this research to clinical practice? Patients who have suffered severe trauma or burns (Bjornson et 01. 1979) or who are immunosuppressed after organ trans-plantation (Marshall 1981) require special protection against bacterial, fungal and viral infections. Active and passive immunization with polyvalent Pseudomonas aeruginosa vaccine or serum reduces the death rate after severe burns (Jones et al. 1979) . The experience gained in respiratory intensive therapy units has underlined the importance of maintaining high arterial oxygen concentrations. Cell-mediated immunity has been studied both in vitro (total lymphocyte count, mitogen transformation of lymphocytes) and in vivo (skin reactivity to recall antigens or dinitrochlorobenzene), but the relationship between abnormal findings and the clinical outcome is not always obvious. Similarly, the role of enteral or parenteral hyperalimentation in assisting host defences has not been firmly established.
We know that anergic patients are more likely to die of infections than fully reactive ones (Meakins et 01. 1980) but is this the result of the anergy or is the anergy the manifestation of severe illness? Can attempts to restore reactivity by levamisole (Symoens & Rosenthal 1977) tip the scales in favour of the host? Is there any future for transfusions of neutrophils, or does their short half-life (six hours) limit their usefulness? Are we any nearer today than we were 70 years ago to achieving Sir Ralph Bloomfield Bennington's ambition to 'stimulate the phagocytes'?
These are among the many unanswered questions which await further clinical and laboratory investigation.
